Searchable abstracts of presentations at key conferences in endocrinology

ea0035p733 | Neuroendocrinology | ECE2014

Prolactinemia and clinical outcome following second generation antipsychotics in early onset schizophrenia

Dobrescu Iuliana , Trutescu Carmen , Kobylinska Liana , Rad Florina , Petrescu-Ghenea Cristina , Anghel Gianina Cristina , Mihailescu Ilinca

Introduction: As antipsychotic drugs specifically block the D2 receptors, they induce a certain level of prolactin increase, dependent on the time it takes to dissociate from receptors. A recent review (Besnard et al, 2013) mentions that 18% of men and 47% of women treated with antipsychotics for severe mental illness had an increased prolactin level. Even if the long term effects of hyperprolactinemia can be severe, including low bone density, amenorrhea, breast and ...

ea0032p732 | Obesity | ECE2013

Metabolic side effects of second generation antipsychotic drugs in adolescents

Dobrescu Iuliana , Rad Florina , Anghel Gianina Cristina , Petrescu-Ghenea Cristina , Trutescu Carmen

Introduction: Although for the last 2 decades we have witnessed a rise in the use of second generation antipsychotic treatment in children and adolescents suffering from psychiatric disorders we do not have enough studies in specialty literature to estimate the risks associated with this medication. Recent data and also our clinical experience shows that second generation antipsychotic drugs administration correlates with considerable weight gain and also with altering of gluc...